Jump to section
About this journal
Aims and scope
Future Neurology aims to disseminate basic, translational and clinical research, focusing on the latest advances and their potential impact on the treatment of neurological diseases and disorders. The journal delivers a wide variety of article types including original research, reviews and opinion pieces, all of which are presented in concise, at-a-glance formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vast and quickly evolving area of research.
Coverage encompasses key areas related to neuroscience, neurology and neurodegeneration, including:
- Understanding biological processes within the nervous system
- Mechanisms and pathologies of disease, injury and disorder including neuropsychiatry
- Disease modeling systems utilizing computer, in vitro and animal approaches
- Genetic factors and precision medicine
- Diagnostic and prognostic advances in screening, biomarker and imaging approaches, in addition to their application in the clinic
- Disease risk assessment and epidemiological studies
- Improving current management and treatment approaches
- Identification of novel therapeutic targets and drug delivery systems
- Drug development, clinical testing and safety
- Novel and emerging therapeutics including cell therapy, gene therapy, nanomedicine, immunotherapy and bioelectronics
- Real-world evidence and outcomes research
Future Neurology welcomes unsolicited article proposals.
Journal metrics
Citation metrics
- 0.6 (2023) Impact Factor
- 1.7 (2023) 5 year IF
- 2.1 (2023) CiteScore (Scopus)
- 0.207 (2023) SNIP
- 0.193 (2023) SJR
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Senior Editor:
Levine S, The State University of New York (SUNY) Health Science Center - Brooklyn, USA
Editorial Advisory Board:
Abrams CK, University of Illinois at Chicago, IL, USA
Achiron A, Tel-Aviv University, Israel
Azami M, Ilam University of Medical Sciences, Iran
Baghbanian MS, Mazandaran University of Medical Science, Iran
Biegon A, Stony Brook University, NY, USA
Borji M, Kermanshah University of Medical Sciences, Iran
Bowerman M, Keele University, UK
Brandes A, Institute of Neurological Sciences, Italy
Cacabelos R, EuroEspes Biomedical Research Center, Spain
Cappa SF, Vita Salute San Raffaele University, Italy
Cavanna A E, University of Birmingham, UK
Coppedè F, University of Pisa, Italy
Dodel R, University of Duisburg-Essen, Germany
Gandy S, Mount Sinai School of Medicine, NY, USA
Gauthier S, McGill University, Canada
Gazerani P, Aalborg University, Denmark
Grippo A, Careggi University Hospital, Florence
Izquierdo I, Pontifical Catholic University of Rio Grande do Sul, Brazil
Jacobs AH, Johanniter Hospital Bonn, Germany
Jamil KA, Universiti Teknologi MARA, Malaysia
Jellinger K, Institute of Clinical Neurobiology, Vienna, Austria
Jimenez-Shahed J, Icahn School of Medicine at Mount Sinai, NY, USA
Jurasic MJ, University Clinical Hospital Center Zagreb, Croatia
Lee H-G, The University of Texas at San Antonio, USA
Lu QR, Cincinnati Children’s Hospital Medical Center, OH, USA
Minagar A, Louisiana State University, USA
Monahan K, Stony Brook University, NY, USA
Oster J, Tufts Medical Center, MA, USA
Oterino A, Marqués de Valdecilla University Hospital, Spain
Pearl P, Children’s National Medical Center, USA
Perry G, University of Texas at San Antonio, USA
Rich JN, Cleveland Clinic, OH, USA
Saponjic J, University of Belgrade, Serbia
Schaller B, University of Zurich, Switzerland
Schwartz M, Weizmann Institute of Science, Israel
Sorenson M, Texas A&M University, Texas, USA
Weissert R, University of Regensburg, Germany
Wisniewski T, New York University, USA
Open access
Future Neurology is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
Continuous publication
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors